IBD in children: Lessons for adults

被引：9

作者：

Haller C.A. ^{[1
]}

Markowitz J. ^{[1
]}

机构：

[1] Schneider Children's Hospital, New Hyde Park, NY 11040

来源：

Current Gastroenterology Reports | 2007年 / 9卷 / 6期

关键词：

Enteral Nutrition; Reach Trial;

D O I：

10.1007/s11894-007-0070-8

中图分类号：

学科分类号：

摘要：

When children develop inflammatory bowel disease (IBD), physicians and researchers are presented with a singular opportunity to understand the nature of these chronic, idiopathic illnesses in the earliest stages. Genetic susceptibility factors tend to be common, whereas complicating environmental factors such as cigarette smoking are generally not an issue. As opposed to the case in adult patients, Crohn's disease is usually diagnosed in children at an early, inflammatory phase of the disease. Pediatric ulcerative colitis tends to present with more severe and more extensive involvement than in adults. In both forms of IBD, the severity of disease activity often dictates the need for early aggressive nutritional, immunomodulatory, and biologic therapy. As a result the lessons learned from the evaluation and treatment of children with IBD are critically important to the clinician caring for adults with the same disorders. Copyright © 2007 by Current Medicine Group LLC.

引用

页码：528 / 532

页数：4

共 40 条

[1]

Devadason D., Hussien H., Spray C., Et al., The incidence of ulcerative colitis has doubled since 1999 [abstract], J Pediatr Gastroenterol Nutr, 40, (2005)

[2]

Kugathasan S., Judd R.H., Hoffman R.G., Et al., Epidemiologic and clinical characteristics of children with newly diagnosed inflammatory bowel disease in Wisconsin: A statewide population-based study, J Pediatr, 143, pp. 525-531, (2003)

[3]

Griffiths A.M., Specificities of inflammatory bowel disease in children, Best Pract Res Clin Gastroenterol, 18, pp. 509-523, (2004)

[4]

Ogunbi S.O., Ransom J.A., Sullivan K., Et al., Inflammatory bowel disease in African-American children living in Georgia, Pediatr, 133, pp. 103-107, (1998)

[5]

Kugathasan S., Collins N., Maresso K., Et al., CARD15 gene mutations and the risk for early surgery in pediatric-onset Crohn's disease, Clin Gastroenterol Hepatol, 2, pp. 1003-1009, (2004)

[6]

Russell R.K., Drummond H.E., Nimmo E.E., Et al., Genotype-phenotype analysis in childhood-onset Crohn's disease: NOD2/CARD15 variants consistently predict phenotypic characteristics of severe disease, Inflamm Bowel Dis, 11, pp. 955-964, (2005)

[7]

Rioux J.D., Silverberg M.S., Daly M.J., Et al., Genomewide search in Canadian families with inflammatory bowel disease reveals two novel susceptibility loci, Am J Hum Genet, 66, pp. 1863-1870, (2000)

[8]

Cucchiara S., Latiano A., Palmieri O., Et al., Polymorphisms to tumor necrosis factor-alpha but not MDR1 influence response to medical therapy in pediatric-onset inflammatory bowel disease, Pediatr Gastroenterol Nutr, 44, pp. 171-179, (2007)

[9]

Sawczenko A., Azooz O., Paraszczuk J., Et al., Intestinal inflammation-induced growth retardation acts through IL-6 in rats and depends on the -174 IL-6 G/C polymorphism in children, Proc Nat Acad Sci U S A, 102, pp. 13260-13265, (2005)

[10]

Zholudev A., Zurakowski D., Young W., Et al., Serologic testing with ANCA, ASCA, and Anti-OmpC in children and young adults with Crohn's disease and ulcerative colitis: Diagnostic value and correlation with disease phenotype, Am J Gastroenterol, 99, pp. 2235-2241, (2004)

← 1 2 3 4 →